Literature DB >> 24163536

Double helix flaps for lower leg defects: report of 4 cases.

Roberto Cecchi1, Laura Bartoli, Luigi Brunetti.   

Abstract

Entities:  

Year:  2013        PMID: 24163536      PMCID: PMC3800294          DOI: 10.4103/0974-2077.118425

Source DB:  PubMed          Journal:  J Cutan Aesthet Surg        ISSN: 0974-2077


× No keyword cloud information.
Sir, When a direct closure is not suitable, the reconstruction of surgical defects on the lower extremities may be problematic, because the leg skin is tight and difficult to mobilize. Full or split-thickness skin grafts are generally used to restore larger defects (>4 cm in diameter).[1] However, they often require long healing times and achieve poor aesthetic results. Traditional skin flaps have a limited role at this level, even to restore small or middle size losses, because of the relevant risk of complications such as flap ischemic necrosis, suture dehiscence or infections.[1] In addition, graft or flap failure favours the development of leg ulcers, especially in elderly with vascular deficiencies. Promising results have been recently reported with the use of new flap techniques such as the ‘reducing opposed multi-lobed flap’, the ‘opposed bilateral transposition flap’, and the keystone flap.[234] However, these procedures have been applied only in small case series or single case reports. We report our experience with the use of double helix flaps (DHF) for the reconstruction of large lower extremity defects following tumour excision. This procedure is a variant of the ‘single’ helix flap technique, which was first utilized by Turkaslan et al., in 2009 to restore circular defects in different body regions.[5] Two opposite helix flaps are raised down to the fascia and rotated into the wound. Every flap encompasses the defect radius in width, and it is harvested as an island flap proximally, while its distal half is completely undermined. Deep and superficial interrupted sutures are placed as necessary (we prefer 3-0 vicryl and 3-0 nylon suture). Before our series, the DHF technique had been utilized only in a patient to restore a large surgical defect on the back.[6] However, DHF shows similarities with the traditional “O-to-Z” flap technique (already utilized to restore wide defects on the legs); therefore, it might be considered a variant of that procedure.[7] Over 2 years, the DHF procedure was performed in 4 patients (3 men and 1 woman) aged 69-79 years (mean: 74 years) to cover skin wounds on the lower legs, after excision of skin tumours [Table 1]. The preoperative diagnosis was clinical or, in some cases, histological. Squamous cell carcinomas were excised with 1 cm of free margin, while basal cell carcinomas were treated with Mohs micrographic surgery. Defect sizes varied from 35 × 35 to 50 × 45 mm (mean: 41 × 39 mm).
Table 1

Patient and tumour data

Patient and tumour data No relevant complication was observed during a mean follow-up of 9 months (range 13-5 months). Functional and cosmetic results were satisfactory in all cases. Three patients had a limited distal flap necrosis, which resolved completely within 3 weeks with local medications. Two cases are illustrated in Figures 1 and 2.
Figure 1

(a) Patient 1. Residual defect after Mohs micrographic surgery and double helix flap design, (b) Flaps rotate and advance to cover the defect, (c) Final suture, (d) View after 10 months

Figure 2

(a) Patient 4. Squamous cell carcinoma on the right leg, (b) Incision of double helix flaps to restore the postsurgical wound, (c) View after 5 months

(a) Patient 1. Residual defect after Mohs micrographic surgery and double helix flap design, (b) Flaps rotate and advance to cover the defect, (c) Final suture, (d) View after 10 months (a) Patient 4. Squamous cell carcinoma on the right leg, (b) Incision of double helix flaps to restore the postsurgical wound, (c) View after 5 months Based on our experience, the DHF technique appears an easy, time-sparing and valid procedure for a single-stage coverage of large skin losses, especially when localized on body areas with poor mobile skin, like the lower leg. No modification of the original circular defect shape nor extra skin excision are required. Using two helix flaps rather than a single flap, the defect closure is achieved with a remarkably lesser tension and, consequently, minor risk of flap impairment or other postsurgical complications. Further experiences on larger series are necessary to support our procedural choice.
  5 in total

1.  The keystone fasciocutaneous flap in the reconstruction of lower extremity wounds.

Authors:  Juan-Carlos Martinez; Jonathan L Cook; Clark Otley
Journal:  Dermatol Surg       Date:  2011-12-30       Impact factor: 3.398

2.  Reducing opposed multilobed flaps results in fewer complications than traditional repair techniques when closing medium-sized defects on the leg after excision of skin tumor.

Authors:  Anthony J Dixon; John B Dixon
Journal:  Dermatol Surg       Date:  2006-07       Impact factor: 3.398

3.  Double helix flap to close a massive circular soft-tissue defect.

Authors:  Tamara C Preda; Bruce G Ashford
Journal:  J Plast Reconstr Aesthet Surg       Date:  2010-12-03       Impact factor: 2.740

4.  Reducing opposed multilobed flap repair, a new technique for managing medium-sized low-leg defects following skin cancer surgery.

Authors:  Anthony J Dixon; Mary P Dixon
Journal:  Dermatol Surg       Date:  2004-11       Impact factor: 3.398

5.  Opposed bilateral transposition flap: a simple and effective way to close large defects, especially of the limbs.

Authors:  R Verdolini; S Dhoat; L Bugatti; G Filosa
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-04-01       Impact factor: 6.166

  5 in total
  2 in total

1.  A novel suture retention device for intraoperative tissue support.

Authors:  Allison Stoecker; Stephanie Howerter; Whitney Fancher; William Lear
Journal:  JAAD Case Rep       Date:  2019-05-08

2.  The use of a suture retention device to enhance tissue expansion and healing in the repair of scalp and lower leg wounds.

Authors:  Collin M Blattner; Benjamin Perry; John Young; William Lear
Journal:  JAAD Case Rep       Date:  2018-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.